Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial

Podobne zapisy

• Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
  od: Wechsler, M, i wsp.
  Wydane: (2017)
• OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
  od: Wechsler, M, i wsp.
  Wydane: (2017)
• Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
  od: Benjamin Terrier, i wsp.
  Wydane: (2023-07-01)
• Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
  od: Ravi Ranjan Pradhan, i wsp.
  Wydane: (2019-01-01)
• Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
  od: Giuseppe A. Ramirez, i wsp.
  Wydane: (2022-12-01)